Healthtech & Wellness VC Funds

Boro Capital is a New York-based venture capital firm that focuses on investing in pre-seed and seed-stage startups across various tech sectors. Established in 2017, the firm targets industries like fintech, SaaS, AI, big data, proptech, and cleantech, among others. Boro Capital’s investment approach centers on identifying early-stage tech companies with the potential to scale rapidly. They leverage a network of strategic partnerships with leading investor groups and accelerators, which helps them source high-potential, pre-vetted startups, streamlining their investment process. The firm typically invests in a company’s first round of institutional funding, cutting checks in the pre-seed and seed stages. With a focus on tech-enabled solutions, Boro Capital has built a diverse portfolio, with over 30 investments in areas like financial software, logistics, and biotechnology. Notable investments include companies like DetraPel, Michroma, and Hailify. Boro Capital’s strategy emphasizes early-stage innovation, aiming to support entrepreneurs through the challenging early phases of scaling their companies. The firm’s portfolio reflects a broad industry focus, from AI and machine learning to climate tech and consumer products. Their approach is designed to capitalize on fast-evolving technologies, making them a key player in helping startups navigate the complex journey from ideation to growth​.

Borski Fund is a pioneering venture capital firm based in Amsterdam that focuses on closing the gender gap in venture capital by investing in companies led by women or gender-diverse teams. Founded in 2019 by Simone Brummelhuis and Laura Rooseboom, Borski Fund is named after Johanna Borski, a 19th-century Dutch financier who was instrumental in funding the Dutch Central Bank. The fund is dedicated to supporting female entrepreneurs and teams with at least one female executive with equity stakes, aiming to foster innovation, inclusivity, and economic growth. Borski Fund’s investment thesis is centered around the belief that diversity leads to better decision-making and stronger business outcomes. The fund’s portfolio includes companies across various sectors, including technology and sustainability, with a particular focus on those driven by data and AI. Borski Fund also stands out due to its collaboration with major partners like the Visa Foundation, which recently contributed to expanding the fund to €40 million. This partnership reflects a shared commitment to promoting gender equality in the startup ecosystem, and the fund has made significant strides in empowering women-led businesses across Europe. By creating opportunities for women and gender-diverse teams, Borski Fund is not only addressing the significant investment gap in venture capital but also championing a more equitable and inclusive business environment.

Bose Ventures is the corporate venture capital arm of Bose Corporation, headquartered in Framingham, Massachusetts. Founded in 2015, the fund has up to $50 million allocated for investing in startups building apps, services, or technologies adjacent to the Bose AR platform and broader audio technology ecosystem. The CVC focuses on three core areas — wearables, wellness, and audio — and has made 20 investments across seed through Series B in companies operating in the United States and Europe. The portfolio has produced one unicorn in Whoop (connected fitness wearables), one IPO in Acast (global podcast platform), and five acquisitions including Aaptiv (fitness audio, acquired by Bose). Other portfolio companies include Noise (consumer electronics, most recent investment April 2025), Bragi (wireless earbuds), Beekeeper (B2B workforce productivity), hearX Group (hearing health, led an $8.3 million round), and MedRhythms (digital therapeutics for neurological conditions). As a strategic CVC, Bose Ventures offers portfolio companies access to Bose's engineering teams, acoustic technology platform, global retail and distribution network, and brand credibility — resources that translate into product development advantages and faster paths to market. Managing Director Steve Romine oversees the fund's investment activities. The firm's thesis centers on the belief that audio and sensory technologies are foundational infrastructure for the next generation of health, fitness, and communication products.

Bossanova Investimentos, often referred to as Bossanova Invest, is a prominent venture capital firm based in Brazil, specializing in pre-seed stage investments. Founded in 2011 by Pierre Schurmann and later joined by João Kepler, Bossanova has established itself as the most active micro-VC in Latin America. The firm focuses on B2B and B2B2C technology companies that are innovative, digital, and scalable​​. Bossanova has invested in over 1,200 startups across more than 1,000 companies, making it a significant player in the early-stage investment scene. Their portfolio includes notable exits such as Glovo, Upsie, and Shift​​. They employ a rigorous selection process and offer extensive support to their portfolio companies to ensure rapid growth and success. The firm's investment strategy revolves around startups that are over 1.5 years old, have found a problem-solution fit, and are already operational and generating revenue. They avoid investments in sectors that exclusively target government, e-commerce, games, or hardware that competes with existing portfolio companies​. Bossanova's network includes over 10,000 co-investors, founders, and partner companies, providing a robust ecosystem for startups to thrive. They also offer educational resources through platforms like Clubb.vc, which provides courses and materials on investment, innovation, and business development​​. In addition to traditional equity investments, Bossanova has introduced an innovative investment model via Cédula de Crédito Bancário (CCB), which allows investors to gain exposure to the startup ecosystem with capital protection and fixed returns​​. This approach aims to democratize access to venture capital investments, making it accessible to a broader range of investors.

Boston Seed Capital is a venture capital firm founded in 2011 by Nicole Stata, Peter Blacklow, and David Balter. The firm is based in Boston, Massachusetts, and primarily focuses on early-stage investments in technology-driven industries. Their investment sectors include SaaS, cybersecurity, e-commerce, big data, AI, machine learning, digital media, and marketplaces. Notable investments by Boston Seed Capital include DraftKings, Flywire, and Perch, showcasing their success in backing high-potential startups​ (Boston Seed)​. They are particularly interested in companies that innovate in consumer digital, sports, marketplaces, AI, data, and security. Geographically, Boston Seed Capital concentrates on companies based in Boston and the surrounding areas, leveraging the region's rich entrepreneurial ecosystem​ (Boston Seed)​. Their strategy involves not just providing financial capital but also offering significant operational support and leveraging their extensive network to help startups scale effectively. The firm's leadership includes Nicole Stata, a seasoned entrepreneur and investor with a notable track record, including founding Deploy Solutions and serving as an advisor and board member for various companies​. For startups seeking investment, Boston Seed Capital values innovative ideas and strong entrepreneurial teams. They are committed to building successful businesses that improve life, work, and play through technology​.

Boulder Ventures, established in 1995, is a venture capital firm that focuses on investing in early-stage information technology and life sciences companies. With headquarters in Boulder, Colorado, and an office in the Mid-Atlantic region, the firm leverages decades-long relationships with entrepreneurs and investors to drive its investment strategy. Boulder Ventures has raised eight funds totaling approximately $429 million, with the most recent fund, Boulder Ventures VIII, closing at $58 million in 2022. The firm has a notable track record, having invested in 61 companies, leading to 28 exits and 10 IPOs​. Key investments by Boulder Ventures include companies like Array BioPharma (acquired by Pfizer for $11.8 billion), LeftHand Networks (acquired by HP), and Wall Street on Demand (acquired by Goldman Sachs). The firm’s portfolio is diverse, covering sectors such as software, IT services, storage and communications, and life sciences. Kyle Lefkoff, the founder and general partner, brings over 38 years of venture capital experience. His extensive background includes significant roles in guiding companies through critical growth stages and strategic exits​.

Boundary Capital is a London-based venture capital firm focused on impact investing in early-stage companies that aim to improve lives and deliver strong commercial returns. Their investment strategy centers on technologies in life sciences, engineering, and data science that address critical global challenges such as healthcare, sustainability, and education. By aligning economic success with positive societal impact, Boundary Capital looks for businesses that offer innovative solutions to real-world problems. The firm typically invests in businesses from late seed to Series B stages, targeting returns of 3x within five to seven years. They place a strong emphasis on companies with proven economic potential and intellectual property advantages. Their portfolio includes high-growth companies like Glyconics, which is developing diagnostics for chronic lung diseases, and Echion, which focuses on fast-charging battery technology. Boundary's team combines extensive entrepreneurial and investment expertise. Led by Managing Partner Dan Somers, the firm supports portfolio companies with strategic guidance, leveraging both their financial investment and hands-on operational support.

Bow Capital, established in 2016 and based in Menlo Park, California, is a venture capital firm that leverages its strong connection with the University of California system to access a rich ecosystem of academic and research resources. This partnership provides them with broad access to the UC's 2.6 million faculty, staff, students, and alumni, as well as numerous research centers and medical facilities​. Bow Capital invests primarily in early-stage startups, focusing on sectors such as artificial intelligence, machine learning, big data, and enterprise software. Their portfolio includes notable companies like Ambi Robotics, Heartex, and Linus Biotechnology. The firm aims to bridge the gap between academia and industry, helping to commercialize innovative technologies and scientific discoveries. The investment strategy at Bow Capital includes participating in pre-seed, seed, and Series A funding rounds. They emphasize not only financial support but also strategic guidance and operational expertise, leveraging their network of Silicon Valley founders and industry leaders to help startups grow and succeed​. Notable exits for Bow Capital include companies like RealtyShares, Rimeto, and Skylight, reflecting their ability to identify and nurture high-potential startups to successful outcomes.

Bowery Capital is a venture capital firm based in New York City, specializing in early-stage investments in B2B software startups. Founded by Michael Brown in 2013, Bowery Capital focuses on seed stage investments, particularly in SaaS and marketplace business models. Their investment strategy emphasizes hands-on support, aiming to help startups achieve product-market fit and scalable sales operations early on. Notable investments in Bowery Capital’s portfolio include companies like Wizeline, VNDLY, and Codecademy, demonstrating their expertise in backing transformative tech ventures. Their approach is highly selective, investing in only a few deals each year but providing intensive support through their Acceleration Team. This team aids startups in various areas, such as sales, marketing, and business development, ensuring that founders have the resources and guidance necessary to succeed. Bowery Capital is known for leading investment rounds and taking active roles in the growth of their portfolio companies. Their support extends beyond financial investment, with a dedicated advisory network known as the Revenue Council, which connects startups with industry experts for continuous mentorship and strategic advice.

BoxGroup is a prominent early-stage venture capital firm based in New York City, established in 2009 by David Tisch and Adam Rothenberg. The firm focuses on investing in pre-seed to Series A rounds, targeting sectors such as consumer technology, enterprise software, fintech, healthcare, life sciences, and marketplaces. BoxGroup has built a robust portfolio with notable investments in companies like Plaid, Airtable, Ro, Ramp, Warby Parker, and Harry’s. They are known for their early-stage support and have made over 600 investments, actively backing innovative startups with the potential to disrupt and define new market categories. BoxGroup typically invests between $50,000 to $250,000 per deal, emphasizing conviction in the founding teams they support. Their approach is geography-agnostic, although they have a strong presence in key tech hubs such as New York, Silicon Valley, and Los Angeles. The firm has also seen several successful exits, including high-profile IPOs and acquisitions. They aim to be one of the earliest and most supportive investors, providing strategic guidance and leveraging their extensive network to help startups grow and succeed.

BoxOne Ventures, established in 2018 and based in Montreal, Canada, is a venture capital firm that focuses on early-stage investments across diverse and impactful sectors. The firm invests in companies with strong technology platforms in areas such as biotechnology, computational biology, AI and data analytics, digital health, fintech, and food technology. BoxOne Ventures has built a robust portfolio featuring notable investments like Juvena Therapeutics, which raised $41M to advance therapeutic solutions. Other significant investments include companies like dfuse, a blockchain development platform, and Odd Burger, a plant-based fast food chain. The firm’s strategy includes backing talented entrepreneurs and innovative technologies that aim to make a positive difference globally. The team at BoxOne Ventures comprises experienced founders and investors who are deeply involved in the development and support of their portfolio companies. This hands-on approach helps startups navigate the challenges of scaling and achieving market success.

New Science Ventures (NSV), founded in 2004, is a venture capital firm that focuses on investments in life sciences and information technology. With offices in New York and London, NSV aims to leverage breakthrough science to create significant value. The firm has a diverse portfolio, investing in companies that utilize fundamental, science-based innovations to address large unmet needs. NSV's notable investments include Ventyx Biosciences, which raised $114 million to advance its pipeline of immunology programs, and Paragraf, a company that mass-produces graphene electronics. Other significant portfolio companies are Phase Four, which develops next-generation electric propulsion solutions for satellites, and NorthSea Therapeutics, which focuses on novel treatments for liver-related diseases​. The firm typically invests in early to mid-stage companies and supports them through crucial value inflection points to help them scale. Their investment strategy is grounded in strong intellectual property protection and a long-term view​.

Bragiel Brothers is an early-stage venture capital firm founded in 2016 by brothers Paul and Dan Bragiel, based in San Francisco. The fund primarily invests in pre-seed, seed, and Series A rounds, focusing on high-growth industries such as SaaS, fintech, AI, machine learning, and developer tools. Known for its global outlook, the firm has invested in over 60 companies across various regions and industries. Some notable portfolio companies include unitQ, Token Transit, Inspectify, and Memfault. These investments highlight Bragiel Brothers' commitment to backing innovative startups that tackle critical challenges in sectors like big data, IoT, and software development. What sets Bragiel Brothers apart is their hands-on approach, often providing mentorship and strategic guidance to founders alongside capital. This involvement has led to successful exits, including companies like Punchh and Replay, and has positioned Bragiel Brothers as a key player in nurturing early-stage innovation. The firm's leadership, led by Paul and Dan Bragiel, brings extensive entrepreneurial experience, having advised or invested in top-tier companies like Uber, Niantic (of Pokémon Go fame), and Unity. With this deep network and focus on transformative technology, Bragiel Brothers continues to be a valuable partner for early-stage startups looking to scale globally.

BrahmaX is a venture capital firm that focuses on early to growth-stage investments, particularly in startups across North America and India. The fund specializes in supporting innovative technology-driven companies with the potential to scale globally. Known for its diverse portfolio, BrahmaX has backed companies in sectors such as fintech, AI, and blockchain. The firm operates with a hands-on approach, often engaging closely with founders to help them navigate key challenges and optimize growth. BrahmaX typically targets companies that leverage disruptive technology to create market-leading products, aligning with their mission to drive transformational change across industries. Their portfolio includes notable investments in cutting-edge startups across various industries, aiming to capture opportunities in rapidly evolving markets. BrahmaX emphasizes a data-driven investment strategy, combining rigorous market analysis and deep industry expertise to identify and support the most promising ventures. Their geographic focus spans both developed and emerging markets, making them a global player in the VC ecosystem. The firm remains selective, partnering with teams that exhibit strong leadership and innovative solutions capable of significant market impact.

Brainchild Holdings is a New York-based venture capital firm founded by Kal Vepuri in 2009. It operates as a private investment vehicle, primarily using Vepuri's personal capital to back early-stage, high-potential companies. Brainchild has a diverse portfolio spanning sectors like consumer products, software, health tech, and retail, focusing on companies that challenge the status quo and bring transformational innovations to market. Over the years, Brainchild has made over 135 investments, including notable companies like Warby Parker, ClassPass, Sweetgreen, Seatgeek, Allbirds, and Mirror. These investments have collectively generated over $75 billion in shareholder value through subsequent funding and exits. Brainchild is particularly active in the seed and early-stage phases, often pre-seeding startups and supporting them through their growth journeys. Vepuri's philosophy is centered on finding founders with bold ideas that disrupt traditional industries. With a keen eye for consumer-facing technology and lifestyle brands, Brainchild has built a reputation for identifying future unicorns and market leaders, such as Oscar Health, Forward, and Dataminr. The firm's portfolio also includes stakes in major names like Uber, Peloton, and Pinterest, further showcasing its influence across multiple sectors.

Brand Foundry Ventures is a venture capital firm based in New York, focusing on early-stage investments in consumer brands. Established in 2014 by Andrew Mitchell, the firm has built a portfolio that includes notable companies like Allbirds, Eden Health, and The Wing​. The firm typically leads Series Seed and Series A financing rounds, investing in a wide range of industries such as food and beverage, health care, and consumer technology. Recent investments include Lucky F*ck, Ledgebrook, and Local Infusion​. Brand Foundry Ventures prides itself on its hands-on approach, supporting startups with strategic guidance and leveraging its extensive network to help founders scale their businesses. The firm has made over 120 investments and has had 37 successful exits, showcasing its ability to identify and nurture high-potential startups.

BrandProject is a venture capital firm based in Toronto, Ontario, founded in 2013 by Andrew Black, Andrew Bridge, Jay Bhatti, and Sarah Prevette. The firm specializes in investing in early-stage consumer product, service, and technology companies. BrandProject operates by partnering with founders to accelerate, incubate, and scale their businesses, providing both financial support and operational expertise. BrandProject has raised $54 million for its first venture fund, BrandProject Capital Fund LP, which allows the firm to support founders beyond the early stages of development. The firm typically invests between $500,000 and $5 million in companies, depending on the stage of the startup. They focus on companies that have the potential to disrupt their industries and bring new, innovative products to market. The firm has a strong track record, having invested in 22 companies since its formation. Notable exits include Freshly, which was acquired by Nestle for $1.5 billion, and Hello Products, which was acquired by Colgate-Palmolive. BrandProject's approach involves active participation in the development of their portfolio companies, providing strategic planning, operational support, marketing depth, and more to help these businesses succeed. BrandProject's investment portfolio includes companies like Daily Harvest, Clutch, and Peachy. They continue to focus on identifying market disruptors and supporting their growth to build the iconic consumer brands of tomorrow.

Bread and Butter Ventures, based in Minneapolis, Minnesota, is an early-stage venture capital firm that invests globally while leveraging the region's strong corporate connections and industry expertise. Founded in 2017, the firm focuses on several key sectors including health tech, food tech, and enterprise SaaS. Their portfolio includes notable investments such as Ducky, an automation and workflow software company; Chiyo, which focuses on food and agriculture technology; SocialCrowd, a platform for enterprise applications; and Nest Collaborative, a health tech company providing virtual lactation support. They have made a total of 87 investments, emphasizing their active involvement in the startup ecosystem. Bread and Butter Ventures has also seen successful exits, including Upsie, a technology company that was acquired, and Spoonshot, which was also successfully exited. The firm is led by Managing Partners Brett Brohl and Mary Grove, who bring extensive experience in technology and early-stage investing.

Break Off Capital is a forward-looking venture capital firm that focuses on funding early-stage companies at the cutting edge of technology. With a mission to "fund the future," the firm actively seeks out innovative projects that have the potential to disrupt traditional industries and drive significant technological advancements. Their investment strategy centers on emerging sectors such as quantum computing, artificial intelligence, and other transformative tech domains that promise to reshape the way industries operate. The fund typically supports ventures in their formative stages, providing not only capital but also strategic insights to help startups scale and navigate competitive landscapes. Break Off Capital emphasizes long-term partnerships, working closely with entrepreneurs to refine business models, accelerate product development, and access broader markets. By leveraging their vast network, they help connect portfolio companies with essential resources, strategic partners, and additional investors. The team at Break Off Capital consists of seasoned professionals with diverse backgrounds in finance, technology, and strategic consulting. Key figures include senior adviser Ian, who brings extensive experience from his time at Eastdil, where he co-founded the Hong Kong office and honed his expertise in global capital markets. The team’s collective experience and strategic acumen enable them to identify high-potential ventures and provide the necessary support to turn visionary ideas into reality. Through a blend of capital investment, strategic mentorship, and industry connections, Break Off Capital is committed to backing ventures that are poised to lead the future of technology and innovation​.

Break Trail Ventures is an early-stage venture capital firm based in Columbus, Ohio, and Boulder, Colorado. Founded in 2018, the firm focuses on investing in startups that are innovating in sectors such as consumer products, advanced manufacturing, big data, digital health, e-commerce, mobile, SaaS, and the Internet of Things. The firm has built a diverse portfolio that includes notable companies like Cotopaxi, an outdoor gear brand committed to sustainability; Oiselle, a women's athletic apparel company; and Pepper, a lingerie brand designed for smaller cup sizes. Break Trail Ventures aims to support entrepreneurs who are pioneering new paths in their industries, emphasizing a customer-first approach and solving significant problems. Break Trail Ventures operates with a mission to partner closely with founders, providing not only capital but also strategic guidance to help startups achieve product-market fit and scale effectively. The firm is led by Managing Partner Jay Hirsh, who brings extensive experience in venture capital and entrepreneurship..

Breakaway Ventures is a consumer brand-focused venture capital firm based in Waltham, Massachusetts, founded in 2006 by Dennis Baldwin. The firm invests exclusively in emerging consumer brands — food and beverage, personal care, sports and fitness, wellness, and self-care — targeting companies that have already crossed $2 million in revenue and are seeking $3 million to $8 million in growth capital to reach the next inflection point. Breakaway leads rounds and manages less than $150 million across five private funds, with 37 investments and 17 exits to date. Portfolio companies include Plaza AI (most recent investment, April 2025), XSET (gaming and entertainment), and Lark (clinics and health services). The investment thesis is tightly scoped: the firm backs only consumer brands, at a specific revenue threshold, with a concentrated focus that allows the team to bring genuine category expertise and a deep capabilities network to each portfolio company. Dennis Baldwin leads the firm as Founder and Managing Partner, supported by Principal Jody O'Neill. Breakaway's model holds that consumer brands at their inflection point are best served not by generalist capital but by an investor with operational depth in brand building — one who can accelerate revenue growth and value creation through direct involvement in go-to-market strategy, retail channel expansion, and brand positioning rather than simply deploying capital.

Breakout Labs, founded in 2012 as part of the Thiel Foundation, is an incubator and venture fund that supports early-stage, deep science companies with radical and emerging technologies. The fund provides up to $350,000 in initial funding and extensive support for startups that are too speculative for traditional venture capitalists. Breakout Labs focuses on companies at the intersection of technology, biology, materials, and energy, aiming to transition groundbreaking scientific discoveries from the lab to the market​. Notable portfolio companies include SciBac, which targets antibiotic-resistant diseases through microbiome science, and Azitra, which leverages the skin’s microbiome to treat skin diseases. Other innovative investments include ZymoChem, which develops sustainable chemical production processes, and EpiBone, which grows custom bones using 3D imaging and stem cells​. Breakout Labs has a history of significant follow-on funding for its portfolio companies, totaling over $1 billion. This success underscores their commitment to supporting the entire lifecycle of their investments, from seed to scale. The team, led by Managing Partners Lindy Fishburne and Julia Moore, includes experts who provide strategic guidance and leverage a vast network of founders, corporate partners, and advisors.

Breakout Ventures is a San Francisco-based venture capital firm founded in 2016, focused on early-stage investments in creative bioscience companies. The firm is dedicated to supporting startups that leverage the convergence of biology, chemistry, and technology to develop bio-based solutions aimed at improving human health and sustainability​. Breakout Ventures has raised significant capital, including a $112.5 million Fund II, to back innovative companies at the intersection of technology and biology. Their investment portfolio includes companies like Immusoft, which is working on genetically modifying B cells for sustained therapeutics, and Checkerspot, which uses synthetic biology to produce bio-derived oils​. The firm's investment strategy targets areas such as synthetic biology, cell and gene therapy, biomanufacturing, and carbon transformation, supporting companies from seed to scale. Notable portfolio companies include Cytovale, which focuses on diagnosing immune-mediated diseases, and Ecovative Design, which uses mycelium technology for sustainable materials. The Breakout Ventures team, led by managing partners Lindy Fishburne and Julia Moore, brings extensive experience in supporting science-driven companies. The firm originated from Breakout Labs at the Thiel Foundation, which has a strong history of advancing early-stage deep science startups​.

Breakthrough Energy Ventures, part of the Breakthrough Energy network founded by Bill Gates, focuses on financing and scaling companies that aim to eliminate greenhouse gas emissions globally. With over $3.5 billion in committed capital, BEV invests in more than 110 cutting-edge companies across various stages, from seed to growth. The firm targets technologies capable of significantly reducing greenhouse gases, aiming for at least half a gigaton reduction annually. Key areas of investment include clean hydrogen, long-duration energy storage, sustainable aviation fuel, direct air capture, and green manufacturing. BEV supports companies like H2Pro, which innovates in green hydrogen production, and Heirloom, focused on cost-effective carbon removal. BEV’s strategy involves more than just funding; it provides comprehensive support, including technical, operational, market, and policy expertise to help companies overcome scaling challenges. This holistic approach ensures that new climate technologies can transition from development to widespread commercial adoption. The team at BEV includes experts like Eric Toone, Technical Lead of the Investment Committee, and Megan Wenrich, Vice President of Development. These professionals bring a wealth of knowledge and experience to guide the firm’s investments and initiatives.

Reply is a leading venture capital arm of Reply Group, based in London, with a strong focus on deep tech, IoT, and digital solutions. Known as Breed Reply, it actively invests in early-stage companies developing next-gen technology across Europe, particularly in sectors such as network management, AI, and environmental sustainability. Their portfolio includes notable investments like RazorSecure and Senseye, with a strategy centered around long-term support, from providing funding to mentorship and market access. Reply tends to lead rounds with investments ranging from $1M to $5M, often in companies at the seed and early stages. With around 52 investments to date, their approach is highly hands-on, guiding startups toward scaling and commercialization. Startups with a focus on the Internet of Things (IoT) or other high-impact technologies have a better chance of catching Reply's attention. The firm's leadership includes figures like Gabriele Dini, who drives investment in tech ventures from their London headquarters. For startups looking to connect, Reply values strong product-market fit and innovation, and prefers businesses that have a clear roadmap to market. Approach them with a solid proof of concept and a well-defined problem your tech can solve..

Breega, founded in 2015 and based in Paris, is a dynamic venture capital firm built by founders for founders. They focus on early-stage investments, with a mission to bridge the equity and experience gap in the VC industry. Breega's notable investments include quantum tech startup Alice&Bob, regtech firm Didomi, and French unicorn Exotec. Breega’s industry focus spans various tech sectors, including fintech, quantum technology, regtech, green mobility, and cybersecurity. They have recently launched a €150M Europe Seed III fund to support early-stage tech startups and a $75M Africa Seed I fund to invest in promising African startups. Geographically, Breega is expanding its reach with a strong presence in Europe, particularly France, Spain, and the UK, and is now targeting markets in Africa with new offices in Nigeria and Cape Town. Their investment strategy is hands-on, providing startups with comprehensive support through their "Scaling Squad," a team of experts that assist with operational guidance, talent acquisition, and scaling strategies. Breega aims to invest in companies with the potential for significant social impact alongside commercial success. The team includes key members like Co-founder and COO Maximilien Bacot, and they are known for their collaborative approach and commitment to supporting founders throughout their entrepreneurial journey.

Brewer Lane Ventures is an early-stage venture capital firm based in Boston, Massachusetts, founded in 2019 by John Kim. The firm focuses on investing in fintech and insurtech startups, aiming to transform the financial services and insurance industries. Brewer Lane leverages its deep industry expertise and extensive network to provide strategic guidance and support to its portfolio companies, helping them scale and achieve market leadership. The firm's investment strategy includes backing founders who are reimagining financial services, with a typical investment range of $1 million to $10 million. Brewer Lane Ventures has raised substantial capital for its funds, with its first fund securing around $120 million and its second fund closing at $203 million​. Brewer Lane Ventures' notable investments include companies like Empathy, January, and Codoxo, which focus on various aspects of application software, financial software, and healthcare enterprise systems. The firm is known for its hands-on approach, providing both financial support and strategic advice to help its portfolio companies navigate their growth trajectories successfully.

Breyer Capital is a premier venture capital firm founded by Jim Breyer in 2006. The firm focuses on catalyzing high-impact entrepreneurs across various sectors, including artificial intelligence, digital health, and fintech. Notable investments from Breyer Capital include Facebook, Spotify, 23andMe, and Zoox, with Zoox being acquired by Amazon. Breyer Capital invests in early-stage startups, particularly those in the AI, healthcare, and consumer tech industries. The firm's approach is founder-centric, emphasizing long-term partnerships and hands-on engagement. They typically participate in pre-seed, seed, and Series A funding rounds. Geographically, Breyer Capital has a broad focus, investing in companies across the United States, Europe, and beyond. The firm is headquartered in Menlo Park, California, but also has a significant presence in Austin, Texas. Key figures at Breyer Capital include founder Jim Breyer and partner Daniel Breyer. The team is known for its deep industry connections and strategic guidance, supporting portfolio companies with both capital and mentorship. Breyer Capital's recent investments include Atropos Health, Nimble Robotics, and Elemental Cognition, highlighting their commitment to innovative solutions in AI and healthcare. The firm's long-term vision and robust support structure make it a vital player in the venture capital landscape.

BRI Ventures (BVI) is the corporate venture capital arm of Bank Rakyat Indonesia, Indonesia's largest bank and the country's leading institution focused on micro and SME finance. Founded in 2019 and headquartered in Jakarta, BVI launched Sembrani Nusantara — Indonesia's first venture fund licensed and regulated by the OJK financial services authority. The firm has made 36 investments producing two unicorns, one IPO, and two acquisitions. BVI leads rounds across seed, Series A, and Series B, with check sizes scaling from $1 million at seed to more than $25 million at later stages. Unicorn portfolio companies include Xendit (payment infrastructure) and Bukalapak (e-commerce marketplace). The investment focus began in fintech before expanding to agriculture, healthcare, retail, logistics, and supply chain. The team of 46 includes two partners, six principals, and functional leads across investment, legal, and finance. Leadership includes founding CEO Nicko Widjaja, formerly of MDI Ventures, and Director of Investment Markus Liman Rahardja. BRI Ventures draws on Bank Rakyat Indonesia's unmatched distribution — spanning tens of millions of micro-enterprise customers across the archipelago — to provide portfolio companies with data, distribution, and institutional validation that private investors cannot replicate. The fund's strategic mandate is to accelerate Indonesia's digital economy, particularly for underserved segments that fall outside the reach of traditional banking.

Bridge Investments, based in Chicago, is a private equity firm that focuses on lower middle-market companies across various sectors. The firm invests in diverse industries including technology, healthcare, and consumer products. Some of their notable investments include companies like In Good Taste, which enhances the wine tasting experience, and LegalMation, an AI-powered platform transforming litigation. Bridge Investments emphasizes partnering with dynamic founders and building collaborative relationships to foster sustainable growth. They take a hands-on approach, often involving their experienced team members in strategic guidance and operational support. The team includes co-founders Daniel Goldberg and Robert Goldberg, who bring decades of expertise in law and investment, along with Jason Thomas and Tim Schlidt, who contribute deep insights in venture capital and healthcare investments. Their portfolio showcases a wide range of successful investments, such as Classkick, an educational technology platform, and ConverseNow, a voice AI platform for quick-service restaurants​​. Bridge Investments is committed to creating value and supporting the growth of their portfolio companies through a collaborative and resourceful investment approach.

BrightEdge Fund is the philanthropic impact investment arm of the American Cancer Society (ACS), established in 2019. Headquartered in Kennesaw, Georgia, BrightEdge focuses on accelerating the commercialization of innovations in cancer care. The fund aims to reduce cancer mortality, alleviate pain and suffering, and advance health equity by investing in for-profit, early-stage companies developing cancer-focused therapeutics, diagnostics, and technologies. Notable investments in BrightEdge’s portfolio include Checkmate Pharmaceuticals, an immunotherapy drug developer; Freenome, a biotech company specializing in early cancer detection through liquid biopsy; and TailorMed, which provides patient financial navigation software. The fund has also invested in Catena Biosciences and Clasp Therapeutics. BrightEdge has a strong track record of exits, with companies like Castle Biosciences going public and Tmunity being acquired. The fund leverages the ACS’s extensive research and expertise to mitigate risks associated with health science investments. This affiliation allows BrightEdge to provide valuable insights into the competitive landscape and regulatory environment, enhancing the potential for successful commercialization of its portfolio companies​. Managed by a team of experienced professionals, including Managing Director Alice Pomponio, BrightEdge also serves as a follow-on investor and board observer, working alongside prominent venture capital firms to support its mission. The fund’s current fundraising target is $100 million, aiming to sustain ACS’s life-saving programs and further its impact.

Bright Ventures is a New York-based venture capital firm focused on building inclusively-led, early-stage companies in industries like fintech, digital health, and the future of work. With a mission centered on creating an inclusive economy, they specialize in Pre-Seed and Seed investments, aiming to unlock human potential through technology-driven innovation. Their portfolio includes companies like Mae Health and Options MD, showcasing their commitment to healthcare and financial services. Bright Ventures looks for transformative startups led by diverse founders, leveraging its proprietary "Inclusive Innovation" model to promote sustainable, inclusive business practices. The firm’s founder, Lenore Beirne, and a strong team of partners, including Noradeen Farlekas and Isha Vij, bring leadership and investment expertise, providing not only capital but also leadership coaching and advisory services through programs like their Leadership Accelerator. Based in New York, they have a U.S.-focused investment strategy. Bright Ventures typically leads early rounds and is highly selective, with a preference for companies that align with their inclusive and stakeholder-driven values. For founders looking to engage, the firm values authentic, mission-driven pitches that emphasize both innovation and impact.

BrightEdge is the innovation and impact investment arm of the American Cancer Society (ACS), founded in 2018 and based in Kennesaw, Georgia. A donor-funded philanthropic impact fund, BrightEdge invests in for-profit, early-stage companies developing cancer-focused therapeutics, diagnostics, medical devices, and enabling technologies. Through the end of 2024, the fund has deployed $52 million across 22 companies, with 15 active portfolio companies holding potential to impact 13.4 million patients. The fund invests globally — across the United States, Canada, Europe, and Asia-Pacific. Investments are aligned with ten American Cancer Society mission priority areas, including cancer health equity, patient survivorship, disease prevention, clinical trial accessibility, and care quality. Recent portfolio companies include Signify Bio (in vivo therapeutics, 2024). BrightEdge also runs the BrightEdge Entrepreneurs program to support founders navigating the early stages of cancer innovation. Managing Director Alice Pomponio brings experience from Red Sky Partners and teaches biomedical innovation at MIT; Director of Investments Lucas de Breed leads deal sourcing and execution. BrightEdge distinguishes itself from pure financial investors by reinvesting all financial returns back into the American Cancer Society's scientific and patient advocacy programs, making every exit outcome directly compound the mission. The fund operates with a dual mandate: achieving genuine venture returns while ensuring the ACS remains a financially self-sustaining engine for cancer research for decades ahead.

Brightlands Venture Partners is a venture capital firm based in Geleen, Netherlands, with a strong focus on investing in startups and scale-ups that address key societal challenges in sustainability and health. Established in 2014, the firm manages several funds, including Brightlands Agrifood Ventures, BVP Fund IV, Chemelot Ventures, and Limburg Ventures, with a combined capital of approximately €120 million. The firm primarily invests in sectors like renewable chemistry, regenerative medicine, agri-food, and digital technologies, aiming to support companies that contribute to a sustainable and healthier future. Brightlands Venture Partners has a diverse portfolio of over 70 companies, including Qorium, a pioneer in cell-cultured leather, and PL BioScience, a leader in sustainable cell culture media. Their investment strategy is not only about providing capital but also involves active involvement and support in scaling the companies, leveraging their deep sector expertise. The leadership team at Brightlands includes experienced professionals like Casper Bruens, Marcel Kloosterman, and Kim de Boer, who collectively bring decades of experience in venture capital and the life sciences industry. Their approach is characterized by a strong emphasis on impact investing, aligning financial returns with measurable societal impact.

Brightspark Ventures is a leading Canadian venture capital firm that focuses on early-stage technology companies. Founded in 1999, Brightspark has evolved from a tech incubator into a powerhouse investor in Canada’s tech ecosystem, backing startups from pre-seed to Series A. Their portfolio includes standout companies like Hopper, a unicorn in the travel-tech space, and Potloc, a B2B data platform. The firm invests primarily in sectors like SaaS, fintech, AI, and deep tech, with a mission to democratize venture capital through its innovative model that allows accredited investors to participate via Special Purpose Vehicles (SPVs). Their geographic focus is Canada, but their investments also extend into the U.S. market. Brightspark typically leads or co-leads investment rounds, deploying checks ranging from $1 million to $3 million. They focus heavily on finding groundbreaking technologies and entrepreneurial teams capable of reshaping industries. As of 2024, the firm manages over $75 million in assets and has recently launched its second Canadian Opportunities Fund to capitalize on the momentum in the Canadian tech market. Led by partners like Mark Skapinker and Sophie Forest, Brightspark combines decades of experience with a hands-on approach, providing mentorship and operational support to their portfolio companies, driving their success from seed stages to high-profile exits.

Brightstone Venture Capital is a venture capital firm based in Minneapolis, Minnesota, established in 1985. The firm focuses on early-growth stage investments in technology and life sciences sectors. With a strong track record, Brightstone manages multiple venture partnerships and currently oversees a $100 million fund aimed at supporting innovative startups. Brightstone's portfolio includes notable companies like VRChat, Celcuity, Bite Squad, and StemoniX, which have achieved significant milestones such as IPOs and major acquisitions. For instance, Bite Squad was sold to WAITR Holdings for $321 million, and StemoniX went public on NASDAQ under the ticker VYNT. The firm is led by experienced partners, including David Dalvey, Jeffrey Cowan, and Patrick O'Shaughnessy, who bring deep expertise in venture investing and entrepreneurship. Brightstone is known for its hands-on approach, providing strategic guidance and operational support to help portfolio companies scale and succeed. Brightstone Venture Capital has made 62 investments and has had 25 successful exits, showcasing their ability to identify and nurture high-potential startups. Their investments span various industries, including biotechnology, software, virtual reality, and medical technology​.

Brilliance Ventures is an Israeli venture capital fund founded in 2018 and headquartered in Tel Aviv. The firm invests in core technology companies at growth stages — specifically AI, machine learning, medical technology, and deep tech — deploying $100,000 to $5 million per investment with a sweet spot around $1.5 million. The portfolio spans 15 companies. Co-founded by Keren Maimon (Managing Partner) and Qian Chen (China-based Partner), Brilliance was built around an explicit cross-border mandate: connecting Israeli tech startups with capital and partnerships in China's largest companies. The firm executes investment banking activities alongside its fund operations, including fundraising, mergers and acquisitions, private placements, secondary deals, and IPOs from Asia. This dual capability — fund investment plus deal-structuring expertise — gives portfolio companies access to Chinese corporate buyers and strategic partners at a stage when such relationships are otherwise difficult for Israeli founders to cultivate directly. Investment stages are Series A and Series B. Brilliance's value proposition rests on the observation that Israeli technology, particularly in AI, medtech, and hardware, commands significant strategic interest from Asian acquirers and growth investors — but that most Israeli founders lack the relationships and local knowledge to convert that interest into capital or partnerships. The firm fills that gap through direct China-based representation and a decade of relationship-building across both ecosystems.

Broadview Ventures, founded in 2008 and headquartered in Boston, Massachusetts, is a venture capital firm focused on investing in early-stage life sciences companies. The firm specializes in cardiovascular and neurovascular diseases, aiming to bridge the translational gap between scientific research and clinical application. Broadview Ventures has a robust portfolio that includes companies such as DecImmune Therapeutics, which develops therapies to mitigate injury post-myocardial infarction, and FineHeart, a French medical device company creating innovative cardiac support technologies. Other notable investments include GI Windows, developing non-surgical approaches for treating chronic diseases, and Adient Medical, focusing on absorbable medical devices. The firm has made 79 investments and achieved several successful exits, including Cardialen, VentriNova, and Renovacor. Broadview's investment strategy leverages their extensive industry expertise and network to support companies from seed through later stages of development. Broadview Ventures is led by a team of experienced professionals dedicated to advancing healthcare through innovative solutions. Their strategic focus and targeted investments aim to address unmet medical needs, ultimately improving patient outcomes and advancing the field of cardiovascular and neurovascular health.

Broadway Video Ventures (BVV) is the corporate venture capital arm of Broadway Video, the entertainment company founded by Lorne Michaels — creator and long-running producer of Saturday Night Live. Based in New York City and active since 2011, BVV targets early and growth-stage investments, acquisitions, partnerships, and joint ventures across media, entertainment, and technology. The fund deploys a minimum of $1.1 million and can commit up to $34.3 million in a single investment, with a portfolio of 14 companies across media, SaaS, gaming, and health tech. Notable portfolio companies include Headspace (meditation and mental wellness app, now merged with Ginger to form Headspace Health), Houseparty (social video app, acquired by Epic Games), and Futurefly (gaming). BVV also incubated Above Average, a digital comedy network. The broader Broadway Video library — spanning SNL, The Tonight Show, and other marquee television properties — gives the firm unique access to talent relationships, content licensing opportunities, and entertainment industry networks. BVV's investment thesis is rooted in the belief that media, entertainment, and technology are converging irreversibly, and that a capital partner with deep content industry relationships can offer technology startups distribution, talent, and branding advantages that pure financial investors cannot. The five-partner team evaluates opportunities through the lens of Broadway Video's ability to add strategic value beyond capital.

Bronze VC is an impact-oriented early-stage venture capital firm founded in 2009 by Stephen DeBerry, based in East Palo Alto, California. The firm invests in high-growth technology companies that move social, economic, and environmental disparity toward prosperity, with a thesis centered on deploying emerging technical capabilities into historically overlooked communities — and finding entry points at low valuations that yield strong financial returns alongside social impact. Bronze is listed on the ImpactAssets 50, a recognized benchmark for impact fund managers. Fund I raised $23 million and has been recognized as a top quartile performer by TVPI across US venture capital as measured by Cambridge Associates. Fund II targeted $75 million. The portfolio of 17 companies spans software, fintech, AI, health, and education sectors. Bronze leads rounds at seed and Series A, typically deploying $500,000 to $3 million. Stephen DeBerry is recognized as a leading practitioner of impact investing that does not sacrifice return discipline. Bronze's strategy rests on the observation that historically underserved geographies and demographics have been systematically undercapitalized — creating a valuation gap that disciplined investors can exploit while also driving measurable social outcomes. The firm's track record suggests that inclusion and financial performance are complementary, not competing, investment goals.

Brooklyn Bridge Ventures (BBV), founded in 2012 by Charlie O'Donnell, is a pioneering early-stage venture capital fund based in Brooklyn, New York. BBV primarily focuses on leading or co-leading pre-seed and seed rounds, targeting startups in the New York City area that have raised less than $750,000 in prior funding rounds. BBV has a diverse portfolio, investing in sectors such as B2B SaaS, eCommerce, Fintech, Foodtech, and Healthcare. Some of their notable investments include Hungryroot, Brigit, and Yuvo Health. These companies have seen significant growth and success, reflecting BBV's ability to identify and nurture promising startups. The firm is known for fostering a strong community among founders and professionals, providing extensive support and guidance to early-stage startups. They typically invest around $350,000, focusing on companies with well-researched ideas, working prototypes, or early traction with users or revenue. As of May 2023, BBV announced that it would no longer be making new investments. Despite this, the firm continues to support its existing portfolio companies, helping them navigate growth and sustainability challenges. For startups seeking engagement, BBV's legacy emphasizes the importance of strong preparation and clear demonstration of potential.

Brown Venture Group (BVG) is a venture capital firm founded in 2018, based in Minneapolis, with a mission to invest in Black, Latino, and Indigenous technology entrepreneurs. Their focus is on providing capital, mentorship, and resources to underrepresented founders who are often overlooked by traditional investors. The firm aims to drive economic empowerment through technology, believing that under-resourced entrepreneurs bring unique resilience to the table. BVG operates primarily in early-stage investments and emerging technologies, with a focus on sectors like clean energy, media production, and health tech. Notable investments include Big Navajo Energy, which focuses on sustainable hydrogen production on tribal lands, as well as Nice Healthcare, a portfolio company that raised $30 million for its in-home care services. The leadership team includes co-founders Dr. Paul Campbell and Chris Brooks, both of whom have extensive backgrounds in tech and entrepreneurship. The firm has raised significant backing, including a $10 million commitment from Best Buy, and continues to work toward raising its $50 million inaugural fund​.

Black River Ventures (BRV) is a venture capital firm founded in 2013 and headquartered in Barcelona, Spain, with operations across the European Union and the United States. The firm invests in growth and later-stage technology companies with a particular focus on fintech, data analytics and AI, software and services, and hardware and IoT. BRV manages approximately $20 million in assets and provides capital in the range of $3 million to $20 million, with a typical investment ticket of $5 million to $10 million and a three-to-five-year investment horizon. The portfolio spans 11 investments, including DreamBig Semiconductor (Series B, July 2024). The firm targets both European companies aiming to become global leaders and US technology companies entering the European market, viewing the European online audience of 400 million-plus consumers as a durable and underpenetrated commercial opportunity for well-capitalized growth companies. Managing Partner Evgeny Kaltashev leads the firm with a focus on partnering with visionary growth-stage companies that have demonstrated early market leadership and are seeking smart capital for long-term expansion. BRV's investment strategy is built around a combination of financial return and active partnership — providing operational guidance, market access, and strategic introductions that help portfolio companies accelerate their paths to acquisition or public market exit.

Btomorrow Ventures (BTV) is the corporate venture capital arm of British American Tobacco, established in 2020 and headquartered in London. BTV focuses on building transformative and innovative businesses across sectors such as consumer brands, digital transformation, new technologies, and future sciences, with a strong emphasis on Environmental, Social, and Governance (ESG) criteria. BTV has made notable investments in startups like FlexSea, a UK-based company pioneering sustainable, seaweed-derived bioplastics, and Open Book Extracts, a cannabinoid innovation house in North Carolina. Their portfolio includes diverse companies such as Awake Chocolate in Canada, offering functional caffeinated chocolates, and Hesperos in Florida, known for their Human-on-a-Chip® technology​. The firm typically participates in early to growth-stage funding, with an average check size of $1 million. BTV is known for leading investment rounds and has a keen interest in companies that align with their sustainability and innovation goals. They actively collaborate with their portfolio companies through initiatives like Btomorrow Labs, providing strategic support and global distribution channels. Led by Managing Director Juan Palacios, the BTV team operates primarily from London, offering a blend of financial investment and strategic partnerships to accelerate the growth of ambitious founders and their disruptive technologies.

b2venture (formerly btov Partners) is a European venture capital firm specializing in early-stage investments. The firm focuses on digital and industrial technology companies, providing substantial support from a robust network of angel investors. Headquartered in Berlin, with additional offices in Munich and St. Gallen, b2venture leverages the collective expertise of seasoned entrepreneurs and investors to back innovative startups. b2venture's portfolio includes notable companies such as DeepL, SumUp, Raisin, and Volocopter. The firm has a track record of successful investments and exits, including companies like Exosome Diagnostics and BUX. They primarily invest in pre-seed and seed rounds, with ticket sizes ranging from EUR 0.25 million to 3.5 million, and continue to support their portfolio companies through various stages of growth​​. The firm is known for its strong community of angel investors, who provide not only capital but also mentorship and strategic guidance. This collaborative approach has been instrumental in the growth of many successful startups. For instance, DeepL and SumUp have both benefited significantly from b2venture's early-stage support and extensive network​. In summary, b2venture combines financial investment with hands-on support and a vast network of industry experts to help startups achieve their full potential, making it a key player in the European venture capital landscape.

Buckley Ventures, founded in 2020 by Joshua Buckley and based in San Francisco, focuses on early-stage venture capital investments. The firm has made 35 investments across various sectors including hardware, software, and fintech. Notable investments include Rain AI, a company in the hardware industry; Framework, which specializes in consumer electronics; and Symbolica AI, a firm developing artificial intelligence solutions. Buckley Ventures has also invested in NexHealth, a healthcare software company, and Porter Finance, a trading platform. The firm has seen successful exits from companies like Whereby and ScienceIO. The team, led by Joshua Buckley and supported by Jonathan Choi and Paul Barnes, emphasizes supporting innovative startups with strong growth potential. Buckley Ventures aims to back companies that are poised to make significant impacts in their respective fields, leveraging their expertise and network to help these startups scale effectively.

Builders VC is a San Francisco-based early-stage venture capital firm founded in 2014, with offices in Chicago and Calgary. The firm backs founders solving complex, mission-critical problems in industries that have resisted modernization — healthcare, agriculture, real estate, and industrials. Fund II raised $250 million; the firm has made 91 investments and recorded 28 exits. General Partners Mark Blackwell, Jim Kim, Mike Rosengarten, and Amit Mehta lead an investment team of 21, supplemented by nine Venture Partners across the United States and Canada. Builders leads rounds, typically deploying $500,000 to $9 million. Notable portfolio companies include Udemy (online education), Sprout Social (social media management), Oscar Health (NYSE IPO at $7.92 billion), Bolt Threads (NASDAQ IPO May 2021), Skybox, Context Relevant, and Climate Corp. In February 2025, the firm partnered with the Qatar Investment Authority, and Fund III is actively deploying. The most recent investment is Anori, completed March 2026. Builders VC's thesis is that essential industries — healthcare delivery, food systems, the built environment — are served by legacy infrastructure built decades ago, and that technology companies replacing those systems create durable competitive advantages and large defensible market positions. The firm focuses on businesses where the technology is genuinely mission-critical to the customer, not peripheral, and where switching costs create lasting retention.

Bull City Venture Partners (BCVP) is a Durham, North Carolina-based early-stage venture capital firm founded in 2012 by Jason Caplain and David Jones. Named after Durham's nickname, the firm specializes in B2B software investments across cloud computing, DevOps, e-commerce infrastructure, fintech, and health technology. Fund IV closed at $53 million in June 2022, reflecting sustained LP confidence in the Southeast US tech ecosystem the firm has championed since its founding. BCVP leads pre-seed, seed, and Series A financings, frequently serving as the first institutional investor in a company. Initial checks range from $250,000 to $2 million, with the portfolio extending to 44 companies including Levitate (client engagement software), Place (real estate platform), Kovr.ai (network management), Tiga AI, and Ferretly (social media screening). Cisco Investments is among the firm's limited partners. Co-founder Jason Caplain brings over 25 years of venture capital experience to the partnership. BCVP operates as a hands-on partner from day one, helping founders build organizational foundations, recruit leadership, and navigate early go-to-market decisions. The firm's thesis is that the best B2B software companies can emerge from anywhere, and its track record in the Southeast demonstrates consistent ability to identify and support companies before they reach the attention of larger coastal funds. The team expanded in early 2026, adding a Principal and an Advisor to support continued growth.

Bullish, headquartered in New York City, is an early-stage venture capital firm that focuses on disruptive consumer businesses. Established in 2015, Bullish invests primarily in pre-seed to Series A rounds, with investments ranging from $500,000 to $3 million. The firm has a strong emphasis on leveraging cultural insights and innovative strategies to support its portfolio companies. Bullish's portfolio includes a range of successful and innovative companies. Notable investments include Captain Experiences, a platform for booking guided outdoor adventures; CUUP, a direct-to-consumer lingerie brand; Function of Beauty, which offers customizable hair, skin, and body care products; and FixMyCar, a mobile auto repair service. Other significant investments include Hello Cake, a wellness brand, and Dirty Labs, a company focused on eco-friendly cleaning products. The firm prides itself on providing more than just capital. They offer strategic marketing, branding, and operational support to help their portfolio companies scale effectively. The team at Bullish includes experienced marketers, strategists, and creatives who work closely with founders to navigate the challenges of growing a business.

Bullnet Capital is a venture capital firm based in Madrid, Spain, specializing in high-technology startups. Founded in 2001 by Javier Ulecia and Miguel del Cañizo, Bullnet Capital focuses on companies with proprietary, breakthrough technologies resulting from significant scientific or technical efforts. They seek startups that have sustainable competitive advantages and can stand the test of time. The firm primarily invests in sectors such as computer hardware, semiconductors, software, and healthcare devices. Their investment strategy emphasizes a hands-on approach, where they not only provide financial support but also strategic and managerial assistance to help companies navigate through their growth phases. Bullnet typically invests between €500,000 and €2,000,000 in early-stage startups. Notable portfolio companies include Digital Legends, Anafocus, and Oncovision, which have benefited from Bullnet's extensive support in both financial and strategic dimensions. The team is led by experienced professionals such as Javier Ulecia, who has a background in aeronautical engineering and an MBA from HEC Paris, and Miguel del Cañizo, a telecom engineer with advanced studies in nanotechnology and photonics. Bullnet Capital's approach focuses on fostering deep, long-term relationships with its portfolio companies, ensuring they have the necessary resources and guidance to succeed in competitive and rapidly evolving markets.